- Home
- SWIN vs CVM Comparison
SWIN vs CVM Comparison
Compare SWIN & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- CVM
- Stock Information
- Founded
- SWIN 2017
- CVM 1983
- Country
- SWIN Hong Kong
- CVM United States
- Employees
- SWIN N/A
- CVM N/A
- Industry
- SWIN
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWIN
- CVM Health Care
- Exchange
- SWIN Nasdaq
- CVM Nasdaq
- Market Cap
- SWIN 41.7M
- CVM 40.1M
- IPO Year
- SWIN 2023
- CVM 1987
- Fundamental
- Price
- SWIN $1.50
- CVM $0.39
- Analyst Decision
- SWIN
- CVM
- Analyst Count
- SWIN 0
- CVM 0
- Target Price
- SWIN N/A
- CVM N/A
- AVG Volume (30 Days)
- SWIN 313.2K
- CVM 1.9M
- Earning Date
- SWIN 02-21-2025
- CVM 01-13-2025
- Dividend Yield
- SWIN N/A
- CVM N/A
- EPS Growth
- SWIN N/A
- CVM N/A
- EPS
- SWIN N/A
- CVM N/A
- Revenue
- SWIN $2,419,000.00
- CVM N/A
- Revenue This Year
- SWIN $165,742.30
- CVM N/A
- Revenue Next Year
- SWIN $29.12
- CVM $152.91
- P/E Ratio
- SWIN N/A
- CVM N/A
- Revenue Growth
- SWIN N/A
- CVM N/A
- 52 Week Low
- SWIN $1.28
- CVM $0.36
- 52 Week High
- SWIN $72.55
- CVM $3.08
- Technical
- Relative Strength Index (RSI)
- SWIN 38.48
- CVM 37.15
- Support Level
- SWIN $1.69
- CVM $0.37
- Resistance Level
- SWIN $1.90
- CVM $0.42
- Average True Range (ATR)
- SWIN 0.31
- CVM 0.04
- MACD
- SWIN -0.00
- CVM -0.00
- Stochastic Oscillator
- SWIN 15.63
- CVM 42.12
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.